About us

What is AEPCC?

The Australian Early Psychosis Collaborative Consortium (we call it AEPCC, pronounced ‘APEX’) has been established to improve the care of young people experiencing psychosis.

We’re partnering with researchers, clinicians, lived experience communities, mental health advocacy groups, policy makers and governments across Australia to strengthen clinical services.

AEPCC will make this happen by building a framework for streamlining the translation of research into real-world treatment for young people with early psychosis.

AEPCC is being built to last, and will continue to bring together and support the early psychosis sector for many years to come.

Why it's needed

Psychotic illnesses such as schizophrenia and bipolar disorder are a major cause of premature death and disability in Australia and globally.

Psychosis generally arises in adolescence and young adulthood and often affects normal development, with potential long-term impacts on educational outcomes, physical health, employment and relationships.

It’s vital to identify young people who are at risk of experiencing psychosis as early as possible. Receiving timely, high-quality, evidence-based care not only helps treat symptoms, but also reduces the risk of progression to a lifelong disorder.

Although clinical guidelines have been developed, some variations in treatment remain. Crucial insights gained through AEPCC’s work will be used to create more standardised and continuously refined care, to further improve the lives of young people experiencing psychosis.

What we do

Working with partners from across the early psychosis research, clinical and lived experience communities, AEPCC has established three programs:

A Clinical Trials and Translation Network

A Clinical Quality Registry

A Lived Experience Network

AEPCC has established the first Australian Clinical Trials and Translation Network in early psychosis. 

The network brings together the research, clinical and lived experience community to:

  • set priority areas for early psychosis research; 
  • facilitate collaborative multi-site early psychosis research trials; and 
  • provide a framework for streamlining the translation of research into real-world practice. 

AEPCC is a facilitating clinical trials network, building a national network driving innovation to ensure young people experiencing early psychosis receive the best treatment when they most need it, giving them the very best opportunity to live a full and well life.

AEPCC has established the first clinical quality registry in the Australian youth mental health sector. 

Clinical quality registries collect and analyse routine clinical outcome data from people who receive treatment at clinical services that participate in a registry for a particular condition.

This information can be used to understand the impact of treatments, in turn helping the sector advocate for more and better services – which is still very much needed in the early psychosis sector. 

The AEPCC CQR collects data from participating clinical services to better understand the outcomes of young people who experience early psychosis. 

All Australian early psychosis clinical services will be able to take part.

AEPCC has also established a lived experience network that is created and guided by the early psychosis lived experience community. 

This national network of young people with lived experience of mental ill-health, carers and family members supporting a loved one, will collaborate with the other AEPCC programs to:

  • shape its policies; 
  • identify areas of improvement in early psychosis research and treatment; 
  • advocate for marginalised voices; and 
  • explore ways of raising awareness and combatting stigma. 

Welcome to the Australian Early Psychosis Collaborative Consortium website.

AEPCC does not provide mental health support. If you need support, click below to find contact details for services near you.
Skip to content